Jci_page_head_homepage_01 Jci_page_head_homepage_02
Anne Jarry, Céline Bossard, Chantal Bou-Hanna, Damien Masson, Eric Espaze, Marc G. Denis, Christian L. Laboisse
Published in Volume 118, Issue 3
J Clin Invest. 2008; 118(3):1132–1142 doi:10.1172/JCI32140
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2
Validation of IL-10 depletion in colonic mucosa explants by neutralizing antibodies: decrease in BLC3, an IL-10–inducible gene.

(A) BCL3 immunohistochemistry on paraffin sections of human normal colonic mucosa. BCL3 was present in the nuclei of the majority of epithelial cells (brown) and in a few lamina propria mononuclear cells. Hematoxylin counterstaining. Original magnification, ×400. (B) Relative expression of BCL3 mRNA levels in 24- and 48-h mucosa explant cultures, incubated with anti–IL-10 neutralizing monoclonal antibodies (1 μg/ml) or with isotype mouse IgG1 (control). Total RNA was isolated from each sample and reverse transcribed. BCL3 and β-actin mRNAs were quantified by real-time PCR (see Methods), and the BCL3/β-actin ratio was calculated. Each point represents the mean of duplicate measurements for 1 sample. Horizontal lines represent mean values of 6 different experiments at 24 h and 5 experiments at 48 h.